We've found
8,836
archived clinical trials in
Leukemia
We've found
8,836
archived clinical trials in
Leukemia
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Updated: 7/7/2015
A Phase III, Randomized Study Of Two Different Dosing Schedules Of Erythropoetin In Anemic Patients With Cancer
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Updated: 7/7/2015
Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Status: Enrolling
Updated: 7/7/2015
Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Updated: 7/7/2015
Cross-Sectional Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance
Status: Enrolling
Updated: 7/7/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
Updated: 7/10/2015
High Risk B-Precursor Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 7/10/2015
Click here to add this to my saved trials